4-(2-Oxo-2-piperidin-1-yl-ethoxy)-benzaldehyde, 95.0%, 1g

4-Amino-2-methylquinoline>97.0%(GC)(T)5g

N-(3-((6-((3-(TRIFLUOROMETHYL)PHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)PHENYL)CYCLOPROPANECARBOXAMIDE, 95%, 10mg

1-(Furan-2-yl)butan-1-one, 98+%, 5g

3-(Trifluoromethyl)phenyltrimethylammonium iodide, 98.0%, 5g

o-Anisidine , >=98 %, for synthesis, 2.5 L, glass packaging

8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol, 97%, 250mg

4-isopropyl-1H-pyrazole hydrochloride, 95.0%, 10g

3-Bromo-[1,2,4]triazolo[4,3-a]pyrazine, 98+%, 1g

Fmoc-Leu-OH, 98%, 500g

(S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide, 95.0%, 250mg

1,4-Dibromonaphthalene, 98.0%, 500g

5-Chloro-2-(4-fluorophenyl)pyridine, 95%, 500mg